Subset analyses showed that this association was solely driven by the subset of ERG-negative cancers (p < 0.0001, Fig. 3b) while outcome differences were not seen in ERG-positive cancers (p = 0.1917, Fig. 3c). This evidence concerns the gene ERG and cancer.